Compare
5 stocks, side by sideRelative performance · rebased to 100
ALNYRVMDRPRXONCARGX
| ALNYAlnylam Pharmaceuticals, Inc. | RVMDRevolution Medicines, Inc. | RPRXRoyalty Pharma plc | ONCBeOne Medicines AG | ARGXargenx SE | |
|---|---|---|---|---|---|
| Smart Score | 4/10 | 9/10 | 6/10 | 4/10 | 6/10 |
| Price | $260.15 | $207.14 | $60.59 | $351.36 | $1,007.32 |
| 1 month | +20% | +4.7% | +5.9% | +6.5% | +15% |
| 1 year | -43% | +468% | +71% | +10% | +52% |
| 5 year | +28% | +670% | +86% | +26% | +222% |
| P/E (TTM) | 111.7 | -29.1 | 31.9 | 1033.4 | 31.1 |
| P/E vs sector | +274% | - | +7% | +3360% | +4% |
| Market cap | $39.1B | $37.9B | $31.5B | $28.6B | $55.5B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.